Literature DB >> 27738666

Commentary: Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer.

Jessica Bauer1, Jonas J Staudacher1, Nancy L Krett1, Barbara Jung1.   

Abstract

Entities:  

Year:  2016        PMID： 27738666      PMCID： PMC5058340     

Source DB:  PubMed          Journal:  J Rare Dis Res Treat


× No keyword cloud information.
  15 in total

1.  Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.

Authors:  Barbara H Jung; Stayce E Beck; Jennifer Cabral; Eddy Chau; Betty L Cabrera; Antonio Fiorino; E Julieta Smith; Melanie Bocanegra; John M Carethers
Journal:  Gastroenterology       Date:  2006-11-16       Impact factor: 22.682

Review 2.  Signaling by the TGFβ superfamily.

Authors:  Jeffrey L Wrana
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

Review 3.  Structural insights into BMP receptors: Specificity, activation and inhibition.

Authors:  David Yadin; Petra Knaus; Thomas D Mueller
Journal:  Cytokine Growth Factor Rev       Date:  2015-11-24       Impact factor: 7.638

Review 4.  TGFβ signalling in context.

Authors:  Joan Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2012-09-20       Impact factor: 94.444

Review 5.  Tgf-beta signaling alterations and colon cancer.

Authors:  Naresh Bellam; Boris Pasche
Journal:  Cancer Treat Res       Date:  2010

6.  Effects of activin and TGFβ on p21 in colon cancer.

Authors:  Jessica Bauer; Judith C Sporn; Jennifer Cabral; Jessica Gomez; Barbara Jung
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

Review 7.  Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion.

Authors:  Holli A Loomans; Claudia D Andl
Journal:  Cancers (Basel)       Date:  2014-12-30       Impact factor: 6.639

Review 8.  Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes.

Authors:  Xiaofeng Dai; Liangjian Xiang; Ting Li; Zhonghu Bai
Journal:  J Cancer       Date:  2016-06-23       Impact factor: 4.207

9.  Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation.

Authors:  Daniel R Principe; Brian DeCant; Jonas Staudacher; Dominic Vitello; Riley J Mangan; Elizabeth A Wayne; Emman Mascariñas; Andrew M Diaz; Jessica Bauer; Ronald D McKinney; Khashayarsha Khazaie; Boris Pasche; David W Dawson; Hidayatullah G Munshi; Paul J Grippo; Barbara Jung
Journal:  Oncotarget       Date:  2017-01-17

10.  Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer.

Authors:  Jessica Bauer; Ozkan Ozden; Naomi Akagi; Timothy Carroll; Daniel R Principe; Jonas J Staudacher; Martina E Spehlmann; Lars Eckmann; Paul J Grippo; Barbara Jung
Journal:  Mol Cancer       Date:  2015-10-24       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.